Clinical characteristics | N/n of Patients (%) |
---|---|
Age at diagnosis | |
  < 40 | 2/62(3.2%) |
 40~50 | 18/62 (29.0%) |
 50~60 | 20/62 (32.3%) |
 60~70 | 18/62 (29.0%) |
  ≥ 70 | 4/62 (6.5%) |
FIGO stage | |
 I | 6/62(9.7%) |
 II | 5/62 (8.1%) |
 III | 36/62 (58.1%) |
 IV | 9/62 (14.5%) |
 NAa | 6/62 (9.7%) |
Primary or Recurrent | |
 Primary | 48/62 (77.4%) |
 Recurrent | 14/62 (22.6%) |
Tumor histopathology | |
 High-gradeb serous | 48/62 (77.4%) |
 Clear cell | 5/62 (8.1%) |
 Endometrioid | 3/62 (4.8%) |
 Low-gradec serous | 1/62 (1.6%) |
 Mucinous | 1/62 (1.6%) |
 Othersd | 4/62 (6.5%) |
Self, in addition to ovarian cancer | |
 Breast cancer | 5/62(8.1%) |
 No breast cancer | 18/62 (91.9%) |
Family history | |
 Breast cancer | 3/62(4.8%) |
 Ovarian cancer | 7/62 (11.3%) |
 Pancreatic cancer | 1/62(1.6%) |
 Pancreatic cancer | 1/62(1.6%) |
 Colon cancer | 2/62(3.2%) |
 Other cancer | 18/62(29.0%) |
 Breast or ovarian cancer | 10/62(16.1%) |